Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$533M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Micron Technology
MU
|
+$272M |
| 4 |
Eli Lilly
LLY
|
+$232M |
| 5 |
Super Micro Computer
SMCI
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
NVIDIA
NVDA
|
+$413M |
| 3 |
Tesla
TSLA
|
+$403M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Johnson & Johnson
JNJ
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.66% |
| 2 | Healthcare | 16.81% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Industrials | 9.62% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXIA
3001
DELISTED
AXIA Energia
AXIA
| $283K | ﹤0.01% |
49,377
-26,520
| -35% | -$151K |
|
3002
ALX Oncology
ALXO
$278M
| $283K | ﹤0.01% |
155,300
-282,900
| -65% | -$1.05M |
|
3003
Virax Biolabs
VRAX
$2.22M
| $282K | ﹤0.01% |
5,816
+5,376
| +1,222% | +$309K |
|
|
AVDL
3004
DELISTED
Avadel Pharmaceuticals
AVDL
| $282K | ﹤0.01% |
21,500
-42,896
| -67% | -$653K |
|
3005
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $281K | ﹤0.01% |
5,870
-26,039
| -82% | -$1.16M |
|
3006
Ebang International Holdings
EBON
$12.3M
| $281K | ﹤0.01% |
46,613
+900
| +2% | +$5.45K |
|
3007
Comscore
SCOR
$108M
| $281K | ﹤0.01% |
41,321
-4,014
| -9% | -$38.9K |
|
3008
SB Financial Group
SBFG
$171M
| $278K | ﹤0.01% |
13,525
-1,700
| -11% | -$27.9K |
|
|
TRIB
3009
Trinity Biotech
TRIB
$7.86M
| $275K | ﹤0.01% |
8,338
-510
| -6% | -$34.5K |
|
3010
Lyell Immunopharma
LYEL
$347M
| $272K | ﹤0.01% |
9,870
+2,255
| +30% | +$66.3K |
|
3011
Vanguard Consumer Discretionary ETF
VCR
$6.11B
| $272K | ﹤0.01% |
800
-1,101
| -58% | -$352K |
|
|
MTA
3012
Metalla Royalty & Streaming
MTA
$854M
| $271K | ﹤0.01% |
87,600
+3,300
| +4% | +$9.7K |
|
3013
Smith-Midland
SMID
$147M
| $270K | ﹤0.01% |
8,100
-2,600
| -24% | -$83.2K |
|
3014
Willamette Valley Vineyards
WVVI
$12M
| $270K | ﹤0.01% |
77,652
-2,300
| -3% | -$8.6K |
|
3015
ProShares Ultra Bitcoin ETF
BITU
$341M
| $269K | ﹤0.01% |
+10,400
| New | +$266K |
|
|
NREF
3016
NexPoint Real Estate Finance
NREF
$317M
| $269K | ﹤0.01% |
17,200
-1,300
| -7% | -$19.5K |
|
3017
Creative Realities
CREX
$39.3M
| $269K | ﹤0.01% |
58,502
+3,400
| +6% | +$15.4K |
|
3018
Cousins Properties
CUZ
$4.85B
| $268K | ﹤0.01% |
9,100
-20,031
| -69% | -$539K |
|
3019
KORU Medical Systems
KRMD
$154M
| $268K | ﹤0.01% |
+98,100
| New | +$242K |
|
|
SCPH
3020
DELISTED
scPharmaceuticals
SCPH
| $267K | ﹤0.01% |
58,656
-162,344
| -73% | -$785K |
|
|
TBI
3021
Trueblue
TBI
$302M
| $267K | ﹤0.01% |
33,900
-116,700
| -77% | -$1.05M |
|
3022
First Guaranty Bancshares
FGBI
$139M
| $267K | ﹤0.01% |
25,106
+9,791
| +64% | +$99.4K |
|
3023
Equillium
EQ
$138M
| $267K | ﹤0.01% |
321,173
+20,773
| +7% | +$17.3K |
|
3024
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.98B
| $266K | ﹤0.01% |
6,047
-3,053
| -34% | -$132K |
|
3025
Bluerock Homes Trust
BHM
$35.7M
| $266K | ﹤0.01% |
17,800
| – | – |
|
Similar funds
Jim Simons's Q3 2024 Portfolio in Review
As of Q3 2024, Jim Simons held 4,024 positions worth $66.5B, up 13% from $59B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $3.2B of net new capital in Q3 2024, opening 578 new positions and adding to 1,558 existing holdings. Its largest new stake was Micron Technology: 2,604,914 shares worth $270M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $413M trimmed.
- Jim Simons's largest Q3 2024 buy was Micron Technology: 2,604,914 shares worth $270M.
- Jim Simons added most to Microsoft in Q3 2024, an estimated $533M increase.
- Jim Simons's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $413M.
- Jim Simons fully exited Broadcom in Q3 2024, selling an estimated $472M.
- Jim Simons's ten largest holdings make up 11% of its $66.5B portfolio in Q3 2024.
- Jim Simons opened 578 new positions and closed 539 in Q3 2024.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $66.5B.
Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.